TY - JOUR
T1 - De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies
AU - Hamanaka, Kohei
AU - Sugawara, Yuji
AU - Shimoji, Takeyoshi
AU - Nordtveit, Tone Irene
AU - Kato, Mitsuhiro
AU - Nakashima, Mitsuko
AU - Saitsu, Hirotomo
AU - Suzuki, Toshimitsu
AU - Yamakawa, Kazuhiro
AU - Aukrust, Ingvild
AU - Houge, Gunnar
AU - Mitsuhashi, Satomi
AU - Takata, Atsushi
AU - Iwama, Kazuhiro
AU - Alkanaq, Ahmed
AU - Fujita, Atsushi
AU - Imagawa, Eri
AU - Mizuguchi, Takeshi
AU - Miyake, Noriko
AU - Miyatake, Satoko
AU - Matsumoto, Naomichi
N1 - Publisher Copyright:
© 2018, European Society of Human Genetics.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Potocki–Shaffer syndrome (PSS) is a contiguous gene syndrome caused by 11p11.2 deletions. PSS is clinically characterized by intellectual disability, craniofacial anomalies, enlarged parietal foramina, and multiple exostoses. PSS occasionally shows autism spectrum disorder, epilepsy, and overgrowth. Some of the clinical features are thought to be associated with haploinsufficiency of two genes in the 11p11.2 region; variants affecting the function of ALX4 cause enlarged parietal foramina and EXT2 lead to multiple exostoses. However, the remaining clinical features were still yet to be linked to specific genetic alterations. In this study, we identified de novo truncating variants in an 11p11.2 gene, PHF21A, in three cases with intellectual disability and craniofacial anomalies. Among these three cases, autism spectrum disorder was recognized in one case, epilepsy in one case, and overgrowth in two cases. This study shows that PHF21A haploinsufficiency results in intellectual disability and craniofacial anomalies and possibly contributes to susceptibility to autism spectrum disorder, epilepsy, and overgrowth, all of which are PSS features.
AB - Potocki–Shaffer syndrome (PSS) is a contiguous gene syndrome caused by 11p11.2 deletions. PSS is clinically characterized by intellectual disability, craniofacial anomalies, enlarged parietal foramina, and multiple exostoses. PSS occasionally shows autism spectrum disorder, epilepsy, and overgrowth. Some of the clinical features are thought to be associated with haploinsufficiency of two genes in the 11p11.2 region; variants affecting the function of ALX4 cause enlarged parietal foramina and EXT2 lead to multiple exostoses. However, the remaining clinical features were still yet to be linked to specific genetic alterations. In this study, we identified de novo truncating variants in an 11p11.2 gene, PHF21A, in three cases with intellectual disability and craniofacial anomalies. Among these three cases, autism spectrum disorder was recognized in one case, epilepsy in one case, and overgrowth in two cases. This study shows that PHF21A haploinsufficiency results in intellectual disability and craniofacial anomalies and possibly contributes to susceptibility to autism spectrum disorder, epilepsy, and overgrowth, all of which are PSS features.
UR - http://www.scopus.com/inward/record.url?scp=85057492312&partnerID=8YFLogxK
U2 - 10.1038/s41431-018-0289-x
DO - 10.1038/s41431-018-0289-x
M3 - Article
C2 - 30487643
AN - SCOPUS:85057492312
SN - 1018-4813
VL - 27
SP - 378
EP - 383
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 3
ER -